← Evidence map

ArticleDiscover oncology2024

KLF4 promotes cisplatin resistance by activating mTORC1 signaling in ovarian cancer.

Wanzhen Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

6 papers cite it

2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 39565445